RSC Advances
Paper
[CH2], 51.7 [CH2CO2CH3], 52.3 [CO2CH3], 74.8 [N–C], 86.4 [N–O– mL) were kept, with occasional shaking, at room temperature
C], 171.5 [CH2CO2Me], 175.1 [CO2Me] ppm. 29Si NMR (305 K, for 1–7 days (a green or blue color of reaction mixture aer
CDCl3, INEPT): rel-2S,3R,5R-isomer, trans-3e (major): d ¼ 26.0; mCPBA addition was observed in several cases, due to the
rel-2R,3S,5R-isomer, cis-3e (minor): d ¼ 26.2 ppm. HRMS (ES-I) intermediacy of nitroso compounds). The reaction mixture was
calcd for C16H31NO6SiH [M + H]+ 362.1993; found 362.1990.
poured into a mixture of EtOAc (15 mL)/NaHCO3 (12 mL,
Methyl
2-(rel-(2S,3S,3aS,6aS)-3-benzyl-(2-tert-butyldime- saturated aqueous solution). The aqueous layer was back-
thylsilyloxy)-hexahydro-2H-cyclopenta[d]isoxazol-3-yl)acetate
extracted with EtOAc (2 ꢂ 5 mL). The combined organic phase
trans-3f. Obtained by the same procedure as 3b with 1.0 eq. of was washed with H2O (10 mL), brine (10 mL) and dried over
TBSOTf and 8 h exposure. Performed on a 1.20 mmol scale. Na2SO4. The solvents were evaporated in vacuo. The residue was
Yield 307 mg (64%), dr > 20 : 1, slightly greenish oil, TLC: Rf ¼ subjected to column chromatography (eluent EtOAc–hexane 1/5
0.85 (hexane–EtOAc, 1/1); 1H NMR (300.13 MHz, 300 K, CDCl3): / 1/3 / 1/2), or to recrystallization from CHCl3–hexane or
d ¼ ꢀ0.21 and 0.09 [2s, 6H, Si(CH3)2], 0.87 [s, 9H, t-Bu], 1.66– Et2O to give the nitro compound 4 or 6 as colorless crystals.
1.80 [m, 4H, CH2Cyc.], 1.90–2.00 and 2.11–2.21 [2m, 2H, CH2Cyc.
]
rel-(4R,6R)-4-Methyl-4-nitro-6-phenyltetrahydro-2H-pyran-2-
2
2.27 [d, 2J ¼ 16.3 Hz, 1H, CHAHB], 2.73 [d, J ¼ 16.3 Hz, 1H, one, 4a. Yield 199 mg (85%), mp ¼ 92–95 C (Et2O), TLC: Rf ¼
CHAHB], 2.83 [d, 2J ¼ 13.7 Hz, 1H, CHCHDPh], 3.02 [d, 2J ¼ 13.7 0.43 (hexane–EtOAc, 1/1). IR (thin layer from CCl4): 1753 (br vs.,
Hz, 1H, CHCHDPh], 3.06 [t, 3J z 3J ¼ 7.3 Hz, 1H, CH], 3.71 [s, 3H, nC]O), 1547 (vs., nasNO2), 1354 (s, nsNO2); 1H NMR (300.13
CO2Me], 5.16 [dd, 3J ¼ 6.4, 3J ¼ 5.3 Hz, 1H, OCH], 7.16–7.31 [m, MHz, 299 K, CDCl3): d ¼ 1.87 [s, 3H, CH3], 2.56 [dd, 2J ¼ 15.5, 3J
ꢁ
5H, Ph] ppm. 13C NMR (75.47 MHz, 300 K, CDCl3): d ¼ ꢀ5.2 and ¼ 3.7 Hz, 1H, CHAHB], 2.63 [dd, 2J ¼ 15.5, J ¼ 11.4 Hz, 1H,
3
ꢀ5.0 [Si(CH3)2], 17.8 [C(CH3)3], 25.9 [C(CH3)3], 26.6, 27.9, 30.6, CHAHB], 2.98 [d, 2J ¼ 16.9 Hz, 1H, CHCHD], 3.35 [d, 2J ¼ 16.9 Hz,
37.4 and 38.9 [CH2], 51.4 [OCH3], 53.3 [CH], 79.0 [C–N], 87.4 1H, CHCHD)], 5.32 [dd, 3J ¼ 11.4, 3J ¼ 3.7 Hz, 1H, CH], 7.33–7.45
[OCH], 126.2 [CHp-Ph], 127.5 and 128.5 [CHo-Ph and CHm-Ph], [m, 5H, Ph] ppm; 13C NMR (75.47 MHz, 299 K, CDCl3): d ¼ 25.8
137.9 [Ci-Ph], 172.0 [OC ¼ O] ppm; 29Si NMR (300 K, CDCl3): d ¼ [CH3], 40.0 [CH2], 42.0 [CH2C]O], 77.2 [CH], 84.4 [CNO2], 126.0
25.1 ppm; HRMS (ES-I) calcd for C22H35NO4SiNa [M + Na]+ and 128.6 [CHo-Ph and m-Ph], 129.1[(CHp-Ph], 137.2 [Ci-Ph], 167.6
428.2228; found 428.2208.
[OC]O] ppm; 14N NMR (299 K, CDCl3): d ¼ 16 (n1/2 z 100 Hz)
Methyl 3-bromomethyl-5-phenyl-(2-tert-butyldimethylsily- ppm. C12H13NO4 (235.24): calcd C, 61.27; H, 5.57; N, 5.95; found
loxy)-isoxazolidin-3-ylacetate 3h. Obtained by the same procedure C, 61.36; H, 5.72; N, 5.85%.
as 3b except with a 3 h exposure. The reaction was performed on a
rel-(4R,6R)-6-(4-Bromophenyl)-4-methyl-4-nitrotetrahydro-
1.50 mmol scale; yield 570 mg (86%), dr 8.0 : 1 (inseparable 2H-pyran-2-one 4b. Yield 249 mg (79%), mp ¼ 162–165 ꢁC
mixture), TLC: Rf ¼ 0.76 (hexane–EtOAc, 1/1); 1H NMR (300.13 (Et2O), TLC: Rf ¼ 0.33 (hexane–EtOAc, 1/1); 1H NMR (300.13
MHz, 302 K, CDCl3): rel-2S,3R,5R-isomer, trans-3h (major): d ¼ 0.22 MHz, 312 K, CDCl3): d ¼ 1.88 [s, 3H, CH3], 2.55–2.64 [m, 2H,
and 0.26 [2s, 6H, Si(CH3)2], 0.97 [s, 9H, t-Bu], 2.65 [dd, 2J ¼ 13.2, 3J ¼ CH2], 2.97 [d, 2J ¼ 17.2 Hz, 1H, CHAHB], 3.35 [d, 2J ¼ 17.2 Hz, 1H,
10.2 Hz, 1H, CHAHB], 2.92 [dd, 2J ¼ 13.2, 3J ¼ 8.8 Hz, 1H, CHAHB], CHAHB], 5.29 [dd, 3J ¼ 10.5, 3J ¼ 3.5 Hz, 1H, CH], 7.25 [d, 3J ¼ 8.0
3
3.00 [d, 2J ¼ 16.9 Hz, 1H, CHCHD(CO2Me)], 3.12 [d, 2J ¼ 16.9 Hz, 1H, Hz, 2H, CHAr], 7.56 [d, J ¼ 8.0 Hz, 2H, CHAr] ppm; 13C NMR
CHCHD(CO2Me)], 3.64 [d, 2J ¼ 11.0 Hz, 1H, CHEHFBr], 3.72 [s, 3H, (75.47 MHz, 312 K, CDCl3): d ¼ 25.7 [CH3], 40.1 [CH2], 41.6
CO2Me], 3.78 [d, 2J ¼ 11.0 Hz, 1H, CHEHFBr], 5.63 [dd, 3J ¼ 8.8, 3J ¼ [CH2], 76.5 [CH], 83.9 [CNO2], 123.2 [CBr], 127.5 [CAr], 132.2 and
6.6, 1H, CH], 7.28–7.48 [m, 5H, Ph]; rel-2R,3S,5R-isomer, cis-3h 136.3 [CHAr], 166.6 [OC]O] ppm; 14N NMR (312 K, CDCl3): d ¼
(minor): d ¼ 0.04 and 0.20 [2s, 6H, Si(CH3)2], 0.90 [s, 9H, t-Bu], 2.32 13 (n1/2 z 150 Hz) ppm; C12H12BrNO4 (314.13): calcd C, 45.88;
[dd, 2J ¼ 13.2, 3J ¼ 6.6 Hz, 1H, CHAHB], 2.87–3.01 [m, 2H, CHAHB H, 3.85; N, 4.46; found C, 45.62; H, 3.77; N, 4.21%.
and CHCHD(CO2Me), overlaps with major isomer], 3.14 [d, 2J ¼ 16.9
rel-(4S,6R)-6-(4-Bromophenyl)-4-methyl-4-nitrotetrahydro-
Hz, 1H, CHCHD(CO2Me)], 3.67 [d, 2J ¼ 17.6 Hz, 1H, CHEHFBr], 3.72 2H-pyran-2-one 4b0. Yield 198 mg (63%), mp ¼ 111–112 ꢁC
[s, 3H, CO2Me], 3.78 [d, 2J ¼ 17.6 Hz, 1H, CHEHFBr], 5.63 [dd, 3J ¼ (Et2O), TLC: Rf ¼ 0.57 (hexane/EtOAc, 1/1). 1H NMR (300.13
3
10.2, J ¼ 8.1 Hz, 1H, CH], 7.28–7.48 [m, 5H, Ph] ppm; 13C NMR MHz, 323 K, CDCl3): d ¼ 1.77 [s, 3H, CH3], 2.08 [dd, 2J ¼ 14.5, 3J
(75.47 MHz, 302 K, CDCl3): rel-2S,3R,5R-isomer, trans-3h (major): d ¼ 11.7 Hz, 1H, CHAHB], 2.79 [d, 2J ¼ 17.7 Hz, 1H, CHCHD], 2.86
¼ ꢀ5.2 and ꢀ4.8 [Si(CH3)2], 18.0 [C(CH3)3], 25.9 [C(CH3)3], 37.8 and [dd, 2J ¼ 14.5, 3J ¼ 1.7 Hz, 1H, CHAHB], 3.63 [d, 2J ¼ 17.7 Hz, 1H,
37.9 [CH2CO2Me and CH2Br], 42.3 [CH2], 51.7 [OCH3], 77.3 [C–N], CHCHD], 5.27 [dd, 3J ¼ 11.7, 3J ¼ 1.7 Hz, 1H, CH], 7.25 [d,3J ¼ 8.1
80.3 [OCH], 126.4 [CHp-Ph], 128.0 and 128.7 [CHo-Ph and CHm-Ph], Hz, 2H, CHAr], 7.54 [d, J ¼ 8.1 Hz, 2H, CHAr] ppm; 13C NMR
3
139.1 [Ci-Ph], 171.0 [OC ¼ O]; rel-2R,3S,5R-isomer, cis-3h (minor): d ¼ (75.47 MHz, 323 K, CDCl3): d ¼ 27.1 [CH3], 39.6 [CH2], 41.7
ꢀ4.9 and ꢀ4.5 [Si(CH3)2], 17.8 [C(CH3)3], 25.7 [C(CH3)3], 35.1 [CH2], 76.7 [CH], 85.3 [CNO2], 123.0 [CBr], 127.3 [CAr], 132.0 and
[CH2Br], 37.4 [CH2CO2Me], 41.8 [CH2], 51.7 [OCH3], 76.5 [C–N], 84.7 136.5 [CAr], 166.2 [OC ¼ O] ppm. 14N NMR (323 K, CDCl3): d ¼ 13
[OCH], 127.3, 127.7 and 128.2 [CHPh], 140.1 [Ci-Ph], 170.8 [OC ¼ O] (n1/2 z 150 Hz) ppm; C12H12BrNO4 (314.13): calcd C, 45.88; H,
ppm; HRMS (ES-I) calcd for C19H30BrNO4SiNa [M + Na]+ 466.1020 3.85; N, 4.46; found C, 45.91; H, 3.62; N, 4.48%.
and 466.1000; found 466.1023 and 466.1002.
rel-(4S,5S)-4-Methyl-4-nitro-5-phenyltetrahydro-2H-pyran-2-
ꢁ
one 4c. Yield 179 mg (76%), mp ¼ 122–124 C (CHCl3–hexane,
1
2/1), TLC: Rf ¼ 0.36 (hexane–EtOAc, 1/1); H NMR (400.1 MHz,
Nitro lactone 4 formation (second step, see Scheme 3)
2
305 K, CDCl3): d ¼ 1.59 [s, 3H, CH3], 2.80 [d, J ¼ 17.8 Hz, 1H,
General procedure. The nitroso acetal 3 (1.00 mmol) and CHAHB], 3.35 [d, 2J ¼ 17.8 Hz, 1H, CHAHB], 3.38 [dd, 3J ¼ 11.0, 3J
mCPBA (70%, 271 mg, 1.10 mmol) as a solution in CH2Cl2 (3.0 ¼ 5.3 Hz, 1H, CH], 4.51 [dd, 2J ¼ 12.1, 3J ¼ 5.3 Hz, 1H, CHAHB],
12472 | RSC Adv., 2014, 4, 12467–12475
This journal is © The Royal Society of Chemistry 2014